Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Grilli

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|November 27, 2013
Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteriaNicola Petrosillo, Maddalena Giannella, Massimo Antonelli, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 8, 2021
Association of Sofosbuvir and Daclatasvir Plasma Trough Concentrations with Patient-, Treatment-, and Disease-Related Factors Among HIV/HCV-Coinfected PersonsIlaria Mastrorosa, Massimo Tempestilli, Stefania Notari, et al.
Viruses|July 2, 2021
Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) DrugsClaudia Minosse, Cesare E M Gruber, Martina Rueca, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort StudyStefania Cicalini, Simone Lanini, Roberta Gagliardini, et al.
Atherosclerosis|May 20, 2017
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohortPaolo Maggi, Chiara Bellacosa, Armando Leone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIVIlaria Mastrorosa, Carmela Pinnetti, Anna Clelia Brita, et al.
Infectious Diseases and Therapy|March 19, 2026
Effectiveness of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide from Rilpivirine or Other Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in Virologically Suppressed People with HIV: A Retrospective Analysis (DRIVE-SWITCH Study)Roberta Gagliardini, Alessandro Caioli, Marisa Fusto, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 20, 2025
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study)Roberta Gagliardini, Marta Camici, Simone Lanini, et al.
AIDS (London, England)|October 25, 2024
Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognitionAlessandra Vergori, Giulia Del Duca, Patrizia Lorenzini, et al.
Journal of the International AIDS Society|November 15, 2014
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trialMassimiliano Fabbiani, Simona Di Giambenedetto, Eugenia Quiros-Roldan, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|November 27, 2013
Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteriaNicola Petrosillo, Maddalena Giannella, Massimo Antonelli, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 8, 2021
Association of Sofosbuvir and Daclatasvir Plasma Trough Concentrations with Patient-, Treatment-, and Disease-Related Factors Among HIV/HCV-Coinfected PersonsIlaria Mastrorosa, Massimo Tempestilli, Stefania Notari, et al.
Viruses|July 2, 2021
Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) DrugsClaudia Minosse, Cesare E M Gruber, Martina Rueca, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort StudyStefania Cicalini, Simone Lanini, Roberta Gagliardini, et al.
Atherosclerosis|May 20, 2017
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohortPaolo Maggi, Chiara Bellacosa, Armando Leone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIVIlaria Mastrorosa, Carmela Pinnetti, Anna Clelia Brita, et al.
Infectious Diseases and Therapy|March 19, 2026
Effectiveness of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide from Rilpivirine or Other Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in Virologically Suppressed People with HIV: A Retrospective Analysis (DRIVE-SWITCH Study)Roberta Gagliardini, Alessandro Caioli, Marisa Fusto, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 20, 2025
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study)Roberta Gagliardini, Marta Camici, Simone Lanini, et al.
AIDS (London, England)|October 25, 2024
Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognitionAlessandra Vergori, Giulia Del Duca, Patrizia Lorenzini, et al.
Journal of the International AIDS Society|November 15, 2014
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trialMassimiliano Fabbiani, Simona Di Giambenedetto, Eugenia Quiros-Roldan, et al.
Pageof 3